IDR 2260.0
(-3.42%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | 106.26 Billion IDR | 79.45% |
2022 | 59.21 Billion IDR | -73.86% |
2021 | 226.48 Billion IDR | 380.26% |
2020 | 47.15 Billion IDR | 218.7% |
2019 | -39.73 Billion IDR | 49.22% |
2018 | -78.24 Billion IDR | 2.43% |
2017 | -80.19 Billion IDR | -5.54% |
2016 | -75.98 Billion IDR | 1.26% |
2015 | -76.95 Billion IDR | 7.47% |
2014 | -83.16 Billion IDR | -72.98% |
2013 | -48.07 Billion IDR | -348.52% |
2012 | 19.34 Billion IDR | 229.26% |
2011 | 5.87 Billion IDR | -29.28% |
2010 | 8.3 Billion IDR | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q2 | 49.88 Billion IDR | 2.46% |
2024 Q1 | 45.64 Billion IDR | 4.44% |
2023 Q4 | 43.7 Billion IDR | 5.53% |
2023 Q2 | 3.26 Billion IDR | -89.62% |
2023 FY | 106.26 Billion IDR | 79.45% |
2023 Q3 | 41.41 Billion IDR | 1169.86% |
2023 Q1 | 31.41 Billion IDR | -21.72% |
2022 Q2 | -22.4 Billion IDR | -156.65% |
2022 Q4 | 40.13 Billion IDR | 1756.81% |
2022 FY | 59.21 Billion IDR | -73.86% |
2022 Q1 | 39.54 Billion IDR | 178.59% |
2022 Q3 | 2.16 Billion IDR | 109.65% |
2021 Q1 | 119.4 Billion IDR | 86.49% |
2021 FY | 226.48 Billion IDR | 380.26% |
2021 Q3 | 84.75 Billion IDR | -23.27% |
2021 Q4 | -50.32 Billion IDR | -159.38% |
2021 Q2 | 110.45 Billion IDR | -7.5% |
2020 Q4 | 64.03 Billion IDR | 88.87% |
2020 Q2 | -41.06 Billion IDR | -948.12% |
2020 Q3 | 33.9 Billion IDR | 182.55% |
2020 Q1 | -3.91 Billion IDR | 93.45% |
2020 FY | 47.15 Billion IDR | 218.7% |
2019 Q2 | -8.32 Billion IDR | -174.95% |
2019 FY | -39.73 Billion IDR | 49.22% |
2019 Q3 | 17.28 Billion IDR | 307.73% |
2019 Q4 | -59.79 Billion IDR | -445.93% |
2019 Q1 | 11.1 Billion IDR | 129.9% |
2018 Q3 | -12.44 Billion IDR | 30.42% |
2018 Q2 | -17.88 Billion IDR | -32.04% |
2018 Q1 | -13.54 Billion IDR | 68.52% |
2018 FY | -78.24 Billion IDR | 2.43% |
2018 Q4 | -37.13 Billion IDR | -198.35% |
2017 Q2 | -16.72 Billion IDR | -81.85% |
2017 Q1 | -9.19 Billion IDR | 60.49% |
2017 FY | -80.19 Billion IDR | -5.54% |
2017 Q4 | -43.02 Billion IDR | -282.63% |
2017 Q3 | -11.24 Billion IDR | 32.78% |
2016 Q2 | -17.29 Billion IDR | -54.93% |
2016 FY | -75.98 Billion IDR | 1.26% |
2016 Q4 | -23.28 Billion IDR | 5.62% |
2016 Q3 | -24.66 Billion IDR | -42.67% |
2016 Q1 | -11.16 Billion IDR | 39.24% |
2015 Q3 | -25.97 Billion IDR | -48.72% |
2015 Q2 | -17.46 Billion IDR | -15.26% |
2015 Q1 | -15.15 Billion IDR | 41.53% |
2015 FY | -76.95 Billion IDR | 7.47% |
2015 Q4 | -18.36 Billion IDR | 29.27% |
2014 Q1 | -9.42 Billion IDR | -417.87% |
2014 FY | -83.16 Billion IDR | -72.98% |
2014 Q4 | -25.91 Billion IDR | 31.0% |
2014 Q3 | -37.55 Billion IDR | -248.8% |
2014 Q2 | -10.76 Billion IDR | -14.28% |
2013 Q1 | -3.02 Billion IDR | -121.73% |
2013 Q2 | -9.35 Billion IDR | -209.51% |
2013 Q4 | 2.96 Billion IDR | 112.18% |
2013 Q3 | -24.33 Billion IDR | -160.18% |
2013 FY | -48.07 Billion IDR | -348.52% |
2012 Q2 | 1.34 Billion IDR | -40.88% |
2012 Q1 | 2.28 Billion IDR | 101.71% |
2012 FY | 19.34 Billion IDR | 229.26% |
2012 Q3 | 2.34 Billion IDR | 74.14% |
2012 Q4 | 13.9 Billion IDR | 492.2% |
2011 Q3 | 1.58 Billion IDR | 10.81% |
2011 Q2 | 1.43 Billion IDR | -16.7% |
2011 Q4 | 1.13 Billion IDR | -28.83% |
2011 FY | 5.87 Billion IDR | -29.28% |
2011 Q1 | 1.72 Billion IDR | 0.0% |
2010 FY | 8.3 Billion IDR | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
PT Bundamedik Tbk | 211.43 Billion IDR | 49.744% |
PT Metro Healthcare Indonesia Tbk | -36.13 Billion IDR | 394.036% |
PT Medikaloka Hermina Tbk | 780.69 Billion IDR | 86.389% |
PT Mitra Keluarga Karyasehat Tbk | 1207.01 Billion IDR | 91.196% |
PT Murni Sadar Tbk | 15.2 Billion IDR | -598.808% |
PT Famon Awal Bros Sedaya Tbk | 204.41 Billion IDR | 48.018% |
PT Royal Prima Tbk | -4.62 Billion IDR | 2399.001% |
PT Kedoya Adyaraya Tbk | 29.49 Billion IDR | -260.239% |
PT Sarana Meditama Metropolitan Tbk | 47.32 Billion IDR | -124.526% |
PT Siloam International Hospitals Tbk | 1728.28 Billion IDR | 93.852% |